Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Supernus (SUPN)

Supernus to report Q2 2026 results after market close on August 4, 2026

Neutral Impact 3 of 5 earnings Written later

Supernus Pharmaceuticals said it will report second quarter 2026 financial and business results after the market closes on Tuesday, August 4, 2026. The company will hold a conference call and webcast that day at 4:30 p.m. ET, led by CEO Jack Khattar and CFO Tim Dec. The announcement contains no financial results.

Key points

  • Second quarter 2026 results to be released after market close on August 4, 2026
  • Conference call and webcast set for August 4, 2026 at 4:30 p.m. ET
  • Replay to be available on the investor relations website for 60 days after the live call

The filing

CompanySupernus (SUPN)
Form8-K, current report
Filed with the SECJul 22, 2026, 5:07 PM ET
Accession number0001356576-26-000031

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.